Personnel Information

写真a

INADA Kento


Job title

Graduate Student

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 2017.03, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Doctor's Course

Campus Career 【 display / non-display

  • 2018.04
    -
    2019.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Central Clinical Facilities, Professional Development Center, Trainee Resident
  • 2022.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Systemic Organ Regulation, Department of Gastroenterology and Hepatology, Graduate Student

External Career 【 display / non-display

  • 2017.04
    -
    2018.03
    , Trainee Resident

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  1. Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, Shunsuke Ueyama, Chiaki Maeyashiki, Hideki Watanabe, Akiko Kusano-Kitazume, Ayako Sato, Kozue Uchidate, Takehito Asakawa, Sho Watanabe, Yasuhiro Iizuka, Isamu Shibata, Shinya Oooka, Yuko Karakama, Takashi Fujii, Taro Watabe, Keiichi Akahoshi, Minoru Tanabe, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Fukiko Kitahata-Kawai, Sayuri Nitta, Mina Nakagawa, Sei Kakinuma, Ryuichi Okamoto, . Prognostic Significance of C-Reactive Protein in Unresectable Hepatocellular Carcinoma treated with Atezolizumab and Bevacizumab. Hepatol Res. 2023.12; Online ahead of print. ( PubMed, DOI )

  2. Kirino Sakura, Tamaki Nobuharu, Kurosaki Masayuki, Takahashi Yuka, Higuchi Mayu, Itakura Yoshie, Tanaka Yuki, Inada Kento, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Hayakawa Yuka, Kakegawa Tatsuya, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Okamoto Ryuichi, Izumi Namiki. Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population QUANTITATIVE IMAGING IN MEDICINE AND SURGERY. 2023.08; 13 (10): 6493-6502. ( PubMed, DOI )

  3. Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Tsubasa Nobusawa, Hiroaki Matsumoto, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy. J Viral Hepat. 2023.04; 30 (4): 297-302. ( PubMed, DOI )

  4. Kirino Sakura, Tamaki Nobuharu, Kurosaki Masayuki, Kaneko Shun, Inada Kento, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Hayakawa Yuka, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Okamoto Ryuichi, Izumi Namiki. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B(タイトル和訳中) Hepatology Research. 2023.01; 53 (1): 35-42. ( ichushi )

  5. Yamashita K, Kurosaki M, Nakanishi H, Tanaka Y, Ishido S, Inada K, Kirino S, Hayakawa Y, Matsumoto H, Nobusawa T, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Tamaki N, Yasui Y, Tsuchiya K, Takahashi Y, Miyazaki R, Ashikaga T, Enomoto N, Izumi N. Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension. JGH open : an open access journal of gastroenterology and hepatology. 2022.11; 6 (11): 774-781. ( PubMed, DOI )

  6. Hayakawa Y, Tamaki N, Nakanishi H, Kurosaki M, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Okamoto R, Izumi N. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal medicine (Tokyo, Japan). 2022.09; ( PubMed, DOI )

  7. Kirino S, Tamaki N, Kurosaki M, Kaneko S, Inada K, Tanaka Y, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology. 2022.09; 53 (1): 35-42. ( PubMed, DOI )

  8. Leona Osawa, Hiroyuki Nakanishi, Masayuki Kurosaki, Sakura Kirino, Kento Inada, Koji Yamashita, Yuka Hayakawa, Shuhei Sekiguchi, Wan Wang, Mao Okada, Mayu Higuchi, Yasuyuki Komiyama, Kenta Takaura, Hitomi Takada, Shun Kaneko, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Kaoru Tsuchiya, Jun Itakura, Yuka Takahashi, Nobuyuki Enomoto, Namiki Izumi. Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan. Digestive Diseases. 2022.07; 40 (4): 479-488. ( PubMed, DOI )

  9. Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Mayu Higuchi, Kenta Takaura, Shun Kaneko, Chiaki Maeyashiki, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi. Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 2022.05; 37 (9): 1726-1731. ( PubMed, DOI )

  10. Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Hayakawa Y, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Irie T, Ariizumi SI, Kurosaki M, Izumi N. Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment. JGH open : an open access journal of gastroenterology and hepatology. 2022.05; 6 (5): 301-308. ( PubMed, DOI )

  11. Yuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Shun Kaneko, Yuki Tanaka, Shun Ishido, Kento Inada, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi. Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice. Invest New Drugs. 2022.04; 40 (2): 392-402. ( PubMed, DOI )

  12. Shuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Ryuichi Okamoto, Masayuki Kurosaki, Namiki Izumi. Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy Cancer Rep (Hoboken). 2022.03; 5 (11): e1613. ( PubMed, DOI )

  13. Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Yuka Hayakawa, Kento Inada, Yuki Tanaka, Shun Ishido, Sakura Kirino, Koji Yamashita, Tsubasa Nobusawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yuka Takahashi, Hiroyuki Nakanishi, Namiki Izumi. Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma. PLoS One. 2022.03; 17 (3): e0265235. ( PubMed, DOI )

  14. Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Nobuyuki Enomoto, Namiki Izumi. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022.02; 55 (3): 292-301. ( PubMed, DOI )

  15. Kenta Takaura, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Kouji Yamashita, Tomohiro Muto, Leona Osawa, Shuhei Sekiguchi, Yuka Hayakawa, Mayu Higuchi, Shun Kaneko, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Jun Itakura, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Namiki Izumi. The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy. PLoS One. 2022.02; 17 (2): e0264075. ( PubMed, DOI )

  16. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. Journal of Gastroenterology and Hepatology. 2021.10; 36 (10): 2960-2966. ( PubMed, DOI )

  17. Shun Kaneko, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Yuka Hayakawa, Koji Yamashita, Leona Osawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Jun Itakura, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Namiki Izumi. Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. 2021.10; 36 (10): 2943-2951. ( PubMed, DOI )

  18. Kento Inada, Shun Kaneko, Masayuki Kurosaki, Koji Yamashita, Sakura Kirino, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Jun Itakura, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Ryuichi Okamoto, Namiki Izumi. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis. JGH Open. 2021.09; 5 (9): 1085-1091. ( PubMed, DOI )

  19. Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Jun Itakura, Yuka Takahashi, Hiroyuki Nakanishi, Daisuke Asano, Takumi Irie, Yasuyuki Kawachi, Namiki Izumi. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade. Hepatol Res. 2021.08; 51 (8): 902-908. ( PubMed, DOI )

  20. Kaneko Shun, Kurosaki Masayuki, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Itakura Jun, Takahashi Yuka, Nakanishi Hiroyuki, Asano Daisuke, Irie Takumi, Kawachi Yasuyuki, Izumi Namiki. アルブミン-ビリルビングレードにより層別化した肝内胆管癌の予後(Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade) Hepatology Research. 2021.08; 51 (8): 902-908. ( ichushi )

  21. Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Shuhei Sekiguchi, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Nobuyuki Enomoto, Namiki Izumi. Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C. J Med Virol. 2021.06; 93 (6): 3744-3751. ( PubMed, DOI )

  22. Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Namiki Izumi. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. J Viral Hepat. 2021.05; 28 (5): 787-794. ( PubMed, DOI )

  23. Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Sakura Kirino, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Rohit Loomba, Namiki Izumi. Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup. Int J Mol Sci. 2020.12; 22 (1): ( PubMed, DOI )

  24. Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Takuya Nagano, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Akihiko Hoshi, Masayuki Kurosaki, Namiki Izumi. Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis. Hepatol Res. 2020.12; 50 (12): 1375-1385. ( PubMed, DOI )

  25. Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Masayuki Kurosaki, Namiki Izumi. Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib. JGH Open. 2020.12; 4 (6): 1183-1190. ( PubMed, DOI )

  26. Kaneko Shun, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Takeguchi Takaya, Takeguchi Yuko, Nagano Takuya, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Hoshi Akihiko, Kurosaki Masayuki, Izumi Namiki. 肝機能と門脈腫瘍血栓症に基づく進行肝細胞癌に対する戦略(Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis) Hepatology Research. 2020.12; 50 (12): 1375-1385. ( ichushi )

  27. Sakura Kirino, Nobuharu Tamaki, Shun Kaneko, Masayuki Kurosaki, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Keiya Watakabe, Mao Okada, Wan Wang, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Yutaka Yasui, Hiroyuki Nakanishi, Kaoru Tsuchiya, Jun Itakura, Yuka Takahashi, Namiki Izumi. Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog. Journal of Gastroenterology and Hepatology. 2020.09; 35 (9): 1595-1601. ( PubMed, DOI )

  28. Nobuharu Tamaki, Masayuki Kurosaki, Hiroyuki Nakanishi, Jun Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Shuhei Sekiguchi, Yuka Hayakawa, Wan Wang, Mao Okada, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Yuka Takahashi, Namiki Izumi. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B. J Med Virol. 2020.08; 92 (8): 1355-1358. ( PubMed, DOI )

  29. Hiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, Masayuki Kurosaki, Leona Osawa, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Mao Okada, Wang Wan, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Yutaka Yasui, Takamasa Noda, Kaoru Nakanishi, Kaoru Tsuchiya, Jun Itakura, Yuka Takahashi, Namiki Izumi. Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy. Sci Rep. 2020.08; 10 (1): 13566. ( PubMed, DOI )

  30. Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, Sakura Kirino, Kento Inada, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi. Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. Hepatol Res. 2020.08; 50 (8): 996-999. ( PubMed, DOI )

  31. Tamaki Nobuharu, Kurosaki Masayuki, Higuchi Mayu, Kirino Sakura, Inada Kento, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. 進行性線維症患者に対する内視鏡スクリーニング回避を目的としたアルブミン、ビリルビン、血小板基準の検証(Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis) Hepatology Research. 2020.08; 50 (8): 996-999. ( ichushi )

  32. Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mao Okada, Wan Wang, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Namiki Izumi. Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma. PLoS One. 2020.04; 15 (4): e0231828. ( PubMed, DOI )

  33. Shun Kaneko, Kaoru Tsuchiya, Masayuki Kurosaki, Sakura Kirino, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Keiya Watakabe, Mao Okada, Wan Wang, Takao Shimizu, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Takaya Takeguchi, Yuko Takeguchi, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yoshiro Himeno, Namiki Izumi. Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib. Hepatol Res. 2020.01; 50 (1): 137-143. ( PubMed, DOI )

  34. Kaneko Shun, Tsuchiya Kaoru, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Watakabe Keiya, Okada Mao, Wang Wan, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Takeguchi Takaya, Takeguchi Yuko, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Izumi Namiki. レンバチニブ投与下の肝細胞癌患者の生存に関する画像効果判定の3基準(Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib) Hepatology Research. 2020.01; 50 (1): 137-143. ( ichushi )

  35. Wan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mao Okada, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Nobuharu Tamaki, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers (Basel). 2019.10; 11 (10): ( PubMed, DOI )

▼display all

Conference Activities & Talks 【 display / non-display

  1. Kento Inada, Hiroyuki Nakanishi, Shun Ishido, Koji Yamashita, Tsubasa Nobusawa, Yuka Hayakawa, Hiroaki Matsumoto, Tatsuya Kakegawa, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Urara Sakurai, Kazuhiro Taki, Mikito Inokuchi, Masayuki Kurosaki, Namiki Izumi. Diagnostic accuracy of M-NBI for type 0-II early gastric cancer treated with ESD. The 94th Annual Meeting of the Japanese Gastric Cancer Association 2022.03.02 PACIFICO Yokohama

  2. Kento Inada, Hiroyuki Nakanishi, Tomohiro Muto, Sakura Kirino, Koji Yamashita, Leona Osawa, Shuhei Sekiguchi, Yuka Hayakawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Jun Itakura, Yuka Takahashi, Kaoru Tsuchiya, Masayuki Kurosaki, Namiki Izumi. Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion. JDDW 2021 KOBE (The 102nd Congress of the Japan Gastroenterological Endoscopy Society) 2021.11.05 Kobe Convention Center

  3. Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における疾患進行のマーカーおよび肝細胞癌の予測リスクとしてのB型肝炎コア関連抗原(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 日本消化器がん検診学会雑誌 2021.10.01

  4. Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. 狭帯域画像を用いた拡大内視鏡検査で発見された早期胃癌の拡張血管の微小粘膜下浸潤予測に関する臨床的有用性(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). 日本消化器がん検診学会雑誌 2021.10.01

  5. Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. 微小粘膜下浸潤を予測するための狭帯域光観察による拡大内視鏡検査によって発見された早期胃がんにおける拡張血管の臨床的有用性について(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). Gastroenterological Endoscopy 2021.10.01

  6. Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. NBI併用拡大内視鏡検査で発見された早期胃癌の微小粘膜下浸潤の予測における拡張血管の臨床的有用性(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). 日本消化器病学会雑誌 2021.10.01

  7. Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における病勢進行のマーカーおよび肝細胞癌の予測リスク因子としてのB型肝炎コア関連抗原(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 日本消化器病学会雑誌 2021.10.01

  8. Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における疾患進行のマーカーおよび肝細胞癌の予測リスクとしてのB型肝炎コア関連抗原について(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 肝臓 2021.09.01

▼display all